-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Initiates Coverage On CG Oncology with Outperform Rating, Announces Price Target of $70

Benzinga·12/11/2025 14:20:06
Listen to the news
Wedbush analyst Robert Driscoll initiates coverage on CG Oncology (NASDAQ:CGON) with a Outperform rating and announces Price Target of $70.